• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>NCI

NCI

  1. NCI Announces Filing of Form 12b-25

    NCI Announces Filing of Form 12b-25

  2. City of Hope’s Linda Malkas, Ph.D., Appointed to State’s Stem Cell Agency Board

    City of Hope’s Linda Malkas, Ph.D., Appointed to State’s Stem Cell Agency Board

  3. New CDISC Data Standard Aids Development of Therapies for Ebola Virus

    New CDISC Data Standard Aids Development of Therapies for Ebola Virus

  4. Ignyta Announces Full Year 2016 Company Highlights and Financial Results

    Ignyta Announces Full Year 2016 Company Highlights and Financial Results

  5. Seven Bridges Names New CEO and Expands Executive Leadership Team

    Seven Bridges Names New CEO and Expands Executive Leadership Team

  6. Carrefour: Solid 2016 Results

    Carrefour: Solid 2016 Results

  7. Integral Molecular and Integrated BioTherapeutics Initiate Collaboration for Virus Vaccine Discovery

    Integral Molecular and Integrated BioTherapeutics Initiate Collaboration for Virus Vaccine Discovery

  8. AES Achieves 2016 Guidance; Sets Growth Target of 8% to 10% Through 2020

    AES Achieves 2016 Guidance; Sets Growth Target of 8% to 10% Through 2020

©2017 Morningstar Advisor. All right reserved.